John Burthem

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency.

Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency.

Journal: Journal of thrombosis and haemostasis : JTH
Published: July 22, 2022

A diagnostic evaluation of single screen testing for malaria in the returning traveler: A large retrospective cohort study.

A diagnostic evaluation of single screen testing for malaria in the returning traveler: A large retrospective cohort study.

Journal: Academic emergency medicine : official journal of the Society for Academic Emergency Medicine
Published: October 02, 2020

The Use and Effectiveness of an Online Diagnostic Support System for Blood Film Interpretation: Comparative Observational Study.

The Use and Effectiveness of an Online Diagnostic Support System for Blood Film Interpretation: Comparative Observational Study.

Journal: Journal of medical Internet research
Published: June 02, 2020

Switchable foldamer ion channels with antibacterial activity.

Switchable foldamer ion channels with antibacterial activity.

Journal: Chemical science
Published: April 27, 2020

Quantitative Assay of Mutated Nucleophosmin in Acute Myeloid Leukemia.

Quantitative Assay of Mutated Nucleophosmin in Acute Myeloid Leukemia.

Journal: Journal of hematology
Published: June 19, 2019

Dual-action CXCR4-targeting liposomes in leukemia: function blocking and drug delivery.

Dual-action CXCR4-targeting liposomes in leukemia: function blocking and drug delivery.

Journal: Blood advances
Published: March 04, 2019

Synthesis and biological activity of a CXCR4-targeting bis(cyclam) lipid.

Synthesis and biological activity of a CXCR4-targeting bis(cyclam) lipid.

Journal: Organic & biomolecular chemistry
Published: August 30, 2018

ASP2215 in the treatment of relapsed/refractory acute myeloid leukemia with FLT3 mutation: background and design of the ADMIRAL trial.

ASP2215 in the treatment of relapsed/refractory acute myeloid leukemia with FLT3 mutation: background and design of the ADMIRAL trial.

Journal: Future oncology (London, England)
Published: March 03, 2018

Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency.

Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency.

Journal: Blood advances
Published: December 10, 2017

Role of Nucleophosmin Gene Mutation in Leukemogenesis of Acute Myeloid Leukemia.

Role of Nucleophosmin Gene Mutation in Leukemogenesis of Acute Myeloid Leukemia.

Journal: Journal of hematology
Published: December 04, 2017

Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficency.

Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficency.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: October 23, 2016

Successful management of acute myeloid leukaemia in a twin pregnancy - a case report.

Successful management of acute myeloid leukaemia in a twin pregnancy - a case report.

Journal: British journal of haematology
Published: October 22, 2016
Showing 1-12 of 23

Last Updated: 09/26/2026